Antiangiogenic drugs and tyrosine kinases

Anti-Cancer Agents in Medicinal Chemistry

Volumn 8, Issue 5, 2008, Pages 462-469

  Tímár, József ^a   Döme, Balázs ^b  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^b NATIONAL KORANYI INSTITUTE OF PULMONOLOGY   (Hungary)

Author keywords

Antivascular therapy; Kinase inhibitors; Tumor vascularization; Tyrosine kinases

Indexed keywords

2,4 DIMETHYL 5 (2 OXO 1H INDOL 3 YLMETHYLENE) 3 PYRROLEPROPIONIC ACID; ALPHA INTERFERON; ANGIOGENESIS INHIBITOR; AXITINIB; BEVACIZUMAB; CETUXIMAB; CILENGITIDE; COMBRETASTATIN; ENDOSTATIN; ERLOTINIB; FLUOROURACIL; FOLINIC ACID; GEFITINIB; IMATINIB; LAPATINIB; MONOCLONAL ANTIBODY LM 609; N [2 [(4 HYDROXYPHENYL)AMINO] 3 PYRIDINYL] 4 METHOXYBENZENESULFONAMIDE; N ACETYLCOLCHINOL PHOSPHATE; OXALIPLATIN; PAZOPANIB; PROTEIN TYROSINE KINASE INHIBITOR; SEMAXANIB; SORAFENIB; SUNITINIB; THALIDOMIDE; VANDETANIB; VATALANIB; PROTEIN TYROSINE KINASE;

ANTIANGIOGENIC ACTIVITY; ANTIANGIOGENIC THERAPY; BREAST CANCER; CANCER INHIBITION; CLINICAL TRIAL; COLORECTAL CANCER; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; DRUG TOLERABILITY; ENDOTHELIUM CELL; GASTROINTESTINAL STROMAL TUMOR; GLIOMA; HEAD AND NECK CANCER; HUMAN; KIDNEY CANCER; KIDNEY CARCINOMA; LEUKEMIA; LUNG CANCER; LUNG NON SMALL CELL CANCER; MELANOMA; NEUROENDOCRINE TUMOR; NONHUMAN; OVARY CANCER; OVERALL SURVIVAL; PANCREAS CANCER; PANCREAS CARCINOMA; PANCREAS ISLET CELL CARCINOMA; REVIEW; SQUAMOUS CELL CARCINOMA; TUMOR VASCULARIZATION; UNSPECIFIED SIDE EFFECT; DRUG ANTAGONISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); VASCULARIZATION;

ANGIOGENESIS INHIBITORS; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN-TYROSINE KINASES;

EID: 48049113069     PISSN: 18715206     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152008784533035     Document Type: Review

References (80)

1. Ausprunk, D.H.; Folkman, J. Microvasc. Res., 1977, 14, 53.
2. Döme, B.; Hendrix, M.J.; Paku, S.; Tóvári, J.; Tímár, J. Am. J. Pathol., 2007, 170, 1.
3. Paku, S.; Paweletz, N. Lab. Invest., 1991, 65, 334.
4. Morbidelli, L.; Donnini S.; Ziche M. Cancer Treat. Res., 2004, 117, 155.
5. Senger, D.R.; Perruzzi, C.A.; Feder, J.; Dvorak, H.F. Cancer Res., 1986, 946, 5629.
6. Ilan, N.; Madri, J.A. Curr. Opin. Cell Biol., 2003, 15, 515.
7. Vincent, P.A.; Xiao, K.; Buckley, K.M.; Kowalczyk, A.P. Am. J. Physiol. Cell Physiol., 2004, 286, C987.
8. Eliceiri, B.P.; Paul, R; Schwartzberg, P.L.; Hood, J.D.; Leng, J.; Cheresh, D.A. Mol. Cell, 1999, 4, 915.
9. Bellon, G.; Martiny, L.; Robinet, A. Crit. Rev. Oncol. Hematol., 2004, 49, 203.
10. Lewalle, J.M.; Munaut, C.; Pichot, B.; Cataldo, D.; Baramova, E.; Foidart, J.M. J. Cell Physiol., 1995, 165, 475.
11. Duffy, M.J. Curr. Pharm. Des., 2004, 10, 39.
12. Pepper, M.S. Cytokine Growth Factor Rev., 1997, 8, 21.
13. Leibovich, S.J.; Polverini, P.J.; Shepard, H.M.; Wiseman, D.M.; Shively, V.; Nuseir, N. Nature, 1987, 329, 630.
14. Rosenkilde, M.M.; Schwartz, T.W. APMIS, 2004, 112, 481.
15. Hicklin, D.J.; Ellis, L.M. J. Clin. Oncol., 2005, 23, 1011.
16. Presta, M.; Dell'Era, P.; Mitola, S.; Moroni, E.; Ronca, R.; Rusnati, M. Cytokine Growth Factor Rev., 2005, 16, 159.
17. Heldin, C.H.; Westermark, B. Physiol. Rev., 1999, 79, 1283.
18. Hammes, H.P.; Lin J.; Wagner, P.; Feng, Y.; Vom Hagen, F.; Krzizok, T.; Renner, O.; Breier, G.; Brownlee, M.; Deutsch, U. Diabetes, 2004, 53, 1104.
19. Gagne, P.; Akalu, A.; Brooks, P.C. Expert Rev. Anticancer Ther., 2004, 4, 129-40.
20. Brooks, P.C.; Clark, R.A.; Cheresh, D.A. Science, 1994, 264, 569.
21. Brooks, P.C.; Stromblad, S.; Sanders, L.C.; von Schalscha, T.L.; Aimes, R.T.; Stetler-Stevenson, W.G.; Quigley, J.P.; Cheresh D.A. Cell, 1996, 85, 683.
22. Asahara, T.; Kawamoto, A. Am. J. Physiol. Cell Physiol., 2004, 287, C572.
23. Asahara, T.; Takahashi, T.; Masuda, H.; Kalka, C.; Chen, D.; Iwaguro, H.; Inai, Y.; Silver, M.; Isner J.M. EMBO J., 1999, 18, 3964.
24. Yamaguchi, J.; Kusano, K.F.; Masuo, O.; Kawamoto, A.; Silver, M.; Murasawa, S.; Bosch-Marce, M.; Masuda, H.; Losordo, D.W.; Isner, J.M.; Asahara, T. Circulation, 2003, 107, 1322.
25. Döme, B.; Paku, S.; Somlai, B.; Tímár J. J. Pathol., 2002, 197, 355.
26. Pezzella, F.; Pastorino, U.; Tagliabue, E.; Andreola, S.; Sozzi, G.; Gasparini, G.; Menard, S.; Gatter, K.C.; Harris, A.L.; Fox, S.; Buyse, M.; Pilotti, S.; Pierotti, M.; Rilke F. Am. J. Pathol., 1997, 151, 1417.
27. Vermeulen, P.B.; Colpaert, C.; Salgado, R.; Royers, R.; Hellemans, H.; Van Den Heuvel, E.; Goovaerts, G.; Dirix, LY.; Van Marck, E. J. Pathol., 2001, 195, 336.
28. Holash, J.; Wiegand, S.J.; Yancopoulos, G.D. Oncogene, 1999, 18, 5356.
29. Ferrara, N.; Gerber, H.P.; LeCouter, J. Nat. Med., 2003, 9, 669.
30. Maniotis, A.J.; Folberg, R.; Hess, A.; Seftor, E.A.; Gardner, L.M.; Pe'er, J.; Trent, J.M.; Meltzer, P.S.; Hendrix, M.J. Am. J. Pathol., 1999, 155, 739.
31. Thies, A.; Mangold, U.; Moll, I.; Schumacher, U. J. Pathol., 2001, 195, 537.
32. Sharma, N.; Seftor, R.E.; Seftor, E.A.; Gruman, L.M.; Heidger, P.M Jr.; Cohen, M.B.; Lubaroff, D.M.; Hendrix, M.J. Prostate, 2002, 50, 189.
33. Shirakawa, K.; Wakasugi, H.; Heike, Y.; Watanabe, I.; Yamada, S.; Saito, K.; Konishi F. Int. J. Cancer, 2002, 99, 821.
34. Sood A.K.; Seftor E.A.; Fletcher M.S.; Gardner L.M.; Heidger P.M.; Buller R.E.; Seftor RE.; Hendrix MJ. Am. J. Pathol., 2001, 158, 1279.
35. Hendrix, M.J.; Seftor, E.A.; Hess, A.R.; Seftor, R.E. Nat. Rev. Cancer, 2003, 3, 411.
36. Seftor, E.A.; Meltzer, P.S.; Schatteman, G.C.; Gruman, L.M.; Hess, AR.; Kirschmann, D.A.; Seftor, R.E.; Hendrix, M.J. Crit. Rev. Oncol. Hematol., 2002, 44, 17.
37. Straume, O.; Chappuis, P.O.; Salvesen, H.B.; Halvorsen, O.J.; Haukaas, S.A.; Goffin, J.R.; Begin, L.R.; Foulkes, W.D.; Akslen, L.A. Cancer Res., 2002, 62, 6808.
38. Stiver, S.I.; Tan, X.; Brown, L.F.; Hedley-Whyte, E.T.; Dvorak, H.F. J. Neuropathol. Exp. Neurol., 2004, 63, 841.
39. Döme, B.; Timár, J.; Paku, S. J Neuropathol. Exp. Neurol., 2003, 62, 655.
40. Zeltner, T.B.; Caduff, J.H.; Gehr, P.; Pfenninger, J.; Burri, P.H. Respir. Physiol., 1987, 67, 247.
41. Short, R.H.D. Philos. Trans. R. Soc. Lond. Ser. B., 1950, 235, 35.
42. Caduff, J.H.; Fischer, L.C.; Burri, P.H. Anat. Rec., 1986, 216, 154.
43. Patan, S.; Haenni, B.; Burri, P.H. Anat. Embryol., 1993, 187, 121.
44. Djonov, V.; Andres, A.C.; Ziemiecki, A. Microsc. Res. Tech., 2001, 52, 182.
45. Patan, S.; Munn, L.L.; Jain, R.K. Microvasc. Res., 1996, 51, 260.
46. Osawa, M.; Masuda, M.; Kusano, K.; Fujiwara, K. J. Cell Biol., 2002, 158, 773.
47. Tozer, G,M.; Kanthou, C., Baguley, B.C. Nat. Rev. Cancer 2005, 5, 423.
48. Ji, R.C. Cancer Metastasis Rev. 2006, 25, 677.
49. Song, S.; Ewald, A.J.; Stallcup, W.; Werb, Z.; Bergers, G. Nat. Cell Biol. 2005, 7, 870.
50. Hunyadi, L.; Catt, K.J. Mol. Endocrinol., 2006, 20, 953.
51. St. Croix, B.; Rago, C.; Velculescu, V.; Traverso, G.; Romans, K.E.; Montgomery, E.; Lal, A.; Riggins, G.J.; Lengauer, C.; Vogelstein, B.; Kinzler, K.V. Science, 2000, 289, 1197.
52. Huminiecki, L.; Bicknell, R. Genome Res., 2000, 10, 1796.
53. Abe, M., Sato, Y. Angiogenesis, 2001, 4, 289.
54. Tímár, J.; Döme, B.; Paku S. In Molecular Pathomechanisms and New Trends in Drug Research; Kéri, Gy., Tóth, I., Eds.; Taylor & Francis Group, London, 2003; pp. 465-486.
55. Lamont, R.E.; Childs, S. Sci. STKE., 2006, 355, pe39.
56. Baker, C.H.; Pino, M.S.; Fidler, I.J. Neoplasia, 2006, 8, 470.
57. von Tell, D.; Armulik, A.; Betsholtz, C. Exp. Cell Res., 2006, 312, 623.
58. Shibuya, M.; Claesson-Welsh, L. Exp. Cell Res., 2006, 312, 549.
59. www.biocarta.com/pathfiles
60. Bergers, G.; Song, S.; Meyer-Morse, N.; Bergsland, E.; Hanahan, D. J. Clin. Invest., 2003, 111, 1287.
61. Cleaver, O.; Melton, D.A. Nat. Med., 2003, 9, 661.
62. Cao, Y. Semin. Cancer Biol., 2004, 14, 139.
63. Eskens, F. Br. J. Cancer 2004, 90, 1.
64. Fayette, J.; Soria, J.C.; Armand, J.P. Eur. J. Cancer, 2005, 41, 1109.
65. Sleifer, S.; Kruit, W.H.; Stoter, G. Eur. J. Cancer, 2004, 40, 2377.
66. Pugh, C.W.; Ratcliffe, P.J. Nat. Med., 2003, 9, 677.
67. Radford, I.R. Curr. Opin. Investig. Drugs, 2003, 3, 492.
68. Chow, L.Q.M.; Eckhardt, G. J. Clin. Oncol., 2007, 25, 884.
69. Langer, C.J.; Natabe, R.B. Semin. Oncol., 2005, 32, S23.
70. Faivre, S.; Djelloul, S.; Raymond, E. Semin. Oncol., 2006, 33, 407.
71. Marshall, J. Cancer, 2006, 107, 1207.
72. Tabernero, J. Mol. Cancer Res., 2007, 5, 203.
73. Cee, V.J.; Albrecht, B.K.; Geuns-Meyer, S.; Hughes, P.; Bellon, S.; Bready, J.; Caenepeel, S.; Chaffee, S.C.; Coxon, A.; Emery, M.; Fretland, J.; Gallant, P.; Gu, Y.; Hodous, B.L.; Hoffman, D.; Johnson, R.E.; Kendall, R.; Kim, J.L.; Long, A.M.; McGowan, D.; Morrison, M.; Olivieri, P.R.; Patel, V.F.; Polverino, A.; Powers, D.; Rose, P.; Wang, L.; Zhao, H. J. Med. Chem., 2007, 50, 627.
74. Jain, R.K.; Duda, G.G.; Clarke, J.; Loeffler, J.S. Nat. Clin. Pract. Oncol., 2006, 3, 24.
75. Motzer, R.J.; Michaelson, M.D.; Redman, B.G. J. Clin. Oncol., 2006, 24, 16.
76. Gollob, J.A.; Wilhelm, S.; Carter, C.; Kelley, SL. Semin. Oncol., 2006, 33, 392.
77. Wedge, S.R.; Ogilvie, D.J.; Dukes, M. Cancer Res., 2000, 60, 970.
78. Wu, W.; Onn, A.; Isobe, T.; Itasaka, S.; Langley, R.R.; Shitani, T.; Shibuya, K.; Komaki, R.; Ryan, A.J.; Herbst, R.S.; O'Reilly, M.S. Mol. Cancer Ther. 2007, 6, 471.
79. Sano, D.; Kawakami, M.; Fujita, K.; Kimura, M.; Yamashita, Y.; Ishiguro, Y.; Nishimura, G.; Matsuda, H.; Tsukuda, M. Oncol. Rep., 2007, 17, 289.
80. Bianco, C.; Giovannetti, E.; Ciardiello, F.; Mey, V.; Nannizzi, S.; Tortora, G.; Troiani, T; Pasqualetti, F.; Eckhardt, G.; de Liguoro, M.; Ricciardi, S.; Del Tacca, M.; Raben, D.; Cionini, L.; Danesi, R. Clin. Cancer Res., 2006, 12, 7099.